Related references
Note: Only part of the references are listed.Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion
Shailesh Singh et al.
CANCER LETTERS (2009)
G protein-coupled receptors stimulation and the control of cell migration
Mathieu Cotton et al.
CELLULAR SIGNALLING (2009)
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines
Shailesh Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Mechanisms of bone metastasis in prostate cancer: clinical implications
Pavlos Msaouel et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
Jing Fang et al.
CELLULAR SIGNALLING (2007)
GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation
Nicolas Delcourt et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response
Keiichi Koizumi et al.
CANCER SCIENCE (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
R115777 (Zarnestra®)/Zoledronic acid (Zometa®) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation
Michele Caraglia et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress
Cesar Nombela-Arrieta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN
Igor Vivanco et al.
CANCER CELL (2007)
DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration
Ziv Shulman et al.
BLOOD (2006)
The Rap GTPases mediate CXCL13- and sphingosine 1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes
Caylib A. Durand et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
DOCK2 is required in T cell precursors for development of Vαa14 NK T cells
Yuya Kunisaki et al.
JOURNAL OF IMMUNOLOGY (2006)
Chemokines, chemokine receptors, and cancer metastasis
Takashi Kakinuma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: androgen-receptor cofactors and bypass pathways
J Edwards et al.
BJU INTERNATIONAL (2005)
Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase
BW Ennis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The activation of Akt/PKB signaling pathway and cell survival
G Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Chemokine signaling defines novel targets for therapeutic intervention
JM Rodriguez-Frade et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells
AM Mingo-Sion et al.
ONCOGENE (2004)
Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors
A Piiper et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Akt in prostate cancer: Possible role in androgen-independence
PM Ghosh et al.
CURRENT DRUG METABOLISM (2003)
DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1
T Sanui et al.
BLOOD (2003)
An endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not Ras/ERK-dependent signaling in vascular smooth muscle cells
LJ Sundberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR
PF Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Human osteoblasts express functional CXC chemokine receptors 3 and 5: Activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release
G Lisignoli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines
H Nishihara et al.
BLOOD (2002)
The JNK signal transduction pathway
CR Weston et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Rho family proteins: coordinating cell responses
AJ Ridley
TRENDS IN CELL BIOLOGY (2001)
Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration
Y Fukui et al.
NATURE (2001)
Essential role for G proteins in prostate cancer cell growth and signaling
PF Kue et al.
JOURNAL OF UROLOGY (2000)
Role of Rac in controlling the actin cytoskeleton and chemotaxis in motile cells
CY Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Phenotypic and genotypic characterization of commonly used human prostatic cell lines
S Mitchell et al.
BJU INTERNATIONAL (2000)